Trials / Unknown
UnknownNCT04461522
Study on the Outcome of Treatment of Rotator Cuff Injury by Ultrasound-guided Injection
Prospective Cohort Study on the Outcome of Treatment of Rotator Cuff Injury by Ultrasound-guided
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 134 (estimated)
- Sponsor
- Peking University Third Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Rotator cuff injury is a common shoulder joint disease in clinic. If conservative treatment fails to improve pain symptoms and range of motion, the surgical indications are. Numerous studies have shown that the pain of rotator cuff injury usually comes not from the broken tendon, but from periarthritis tendonitis, bursitis or adhesive shoulder capsule, etc. Ultrasound-guided drug injection combined with conventional rehabilitation treatment can significantly improve the pain symptoms and increase joint mobility. This study intends to use prospective cohort study methods, exposed factors for ultrasound-guided injection drug treatment, establish a rotator cuff injury exposure group and the control group of shoulder joint dysfunction queue, whether of ultrasound guided drug injection therapy can increase the shoulder joint function analysis, and explore for the rotator cuff injury method provides the basis of the evidence-based conservative treatment. The establishment of a conservative treatment cohort for rotator cuff injury will also lay the foundation for the accurate rehabilitation treatment of rotator cuff injury.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Ultrasound-guided drug injection | The injection drugs were glucocorticoids and anesthetic drugs (1ml+2% lidocaine hydrochloride 0.5ml+0.9% sodium chloride 0.5ml), and the injection sites were subacromion deltoid bursa/coracoid bursa/biceps longhead tenosynosheath/glenohumeral joint bursa, etc. |
Timeline
- Start date
- 2020-03-10
- Primary completion
- 2021-12-31
- Completion
- 2021-12-31
- First posted
- 2020-07-08
- Last updated
- 2020-07-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04461522. Inclusion in this directory is not an endorsement.